Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Copenhagen University Hospital at Herlev
• Treatments: Bismuth

Criteria

Inclusion Criteria:

• Patients of 18 years or over referred to the Department of Haematology L, Herlev Hospital, with a view to 'cytostatic'? treatment of or radiotherapy for haematological malignancy

Exclusion Criteria:

• Pregnant women and nursing mothers

• No informed consent from patient

• Known hyper sensitivity to bismuth or other tablet content

• Severe renal insufficiency with creatinin clearance below 25 ml/min.

• Patients receiving other treatment for protection of the mucous membrane except cryo treatment of the oral cavity (lumps of ice in the mouth)

• Other experimental treatment within past four weeks.